PRECOL2011-1: Sodium Picophosphate and Magnesium Citrate Versus Polyethylene Glycol as Evacuating Treatment Prior to Colonoscopy: Phase IV Randomized Trial.
Phase 4
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Patients Undergoing Elective Colonoscopy
Both
Patients Undergoing Elective Colonoscopy
Trial Information
PRECOL2011-1: Sodium Picophosphate and Magnesium Citrate Versus Polyethylene Glycol as Evacuating Treatment Prior to Colonoscopy: Phase IV Randomized Trial.
Inclusion Criteria:
• Subjects who are candidate to undergo colonoscopy: Diagnosis Screening Follow-up after
previous polypectomy
- Informed consent
- Age > 18 years
Exclusion Criteria:
- Previous colonic resection
- Severe inflammatory bowel disease (IBD)
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Boston Bowel Preparation Scale value
Outcome Description:
evaluated by two endoscopists who are blinded to treatment assigned at randomization
Outcome Time Frame:
at time of colonscopy
Safety Issue:
No
Principal Investigator
Valentina D'Angelo, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
National Cancer Institute, Naples
Authority:
Italy: Ethics Committee
Study ID:
PRECOL2011-1
NCT ID:
NCT01649674
Start Date:
November 2011
Completion Date:
March 2014
Related Keywords:
- Patients Undergoing Elective Colonoscopy
Name | Location |
|---|
